Latest Regulatory Clearance News

Multistack International has formalised the sale of nearly all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a decisive end to its loss-making operations. The transaction hinges on shareholder and regulatory approvals, with completion targeted for June 30, 2026.

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.

Genesis Minerals is set to acquire Magnetic Resources for approximately A$639 million, offering Magnetic shareholders a 25-35% premium. The deal unlocks synergies at the Lady Julie Gold Project, where an updated underground production target extends mine life to 14-19 years with improved economics.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.

National Storage REIT securityholders have overwhelmingly approved the Brookfield-GIC consortium's $2.86 per security cash acquisition, paving the way for a $6.7 billion transaction expected to complete in May 2026.

Blackstone Minerals has cleared a major regulatory hurdle with the lifting of a Cease and Desist Order at its Mankayan Copper-Gold Project, setting the stage for a pivotal Pre-Feasibility Study drilling campaign.

Orpheus Uranium has secured key regulatory approvals for advanced exploration across multiple projects and raised $4.37 million, including a cornerstone investment from IsoEnergy, as it prepares for a busy 2026 drilling season.

Insignia Financial Limited will be removed from the S&P/ASX 200 Index ahead of its acquisition by Daintree BidCo, with 4DMedical Limited stepping in on April 20, 2026.

Insignia Financial shareholders met on 13 April 2026 and overwhelmingly backed a $4.80 per share acquisition scheme by CC Capital, valuing the company at about $3.3 billion and offering a near 57% premium to pre-offer prices.

Diatreme Resources is consolidating its Far North Queensland silica assets by selling the Cape Flattery Silica Project to its joint venture with Sibelco, securing $7.4 million in fresh capital and streamlining project ownership ahead of key development milestones.